A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Brod M;Brod M; Wolden M; Christensen T; Bushnell DM
  • Source:
    Diabetes, obesity & metabolism [Diabetes Obes Metab] 2013 Jun; Vol. 15 (6), pp. 546-57. Date of Electronic Publication: 2013 Feb 25.
  • Publication Type:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
    • Publication Information:
      Original Publication: Oxford : Wiley-Blackwell, c1999-
    • Subject Terms:
      Quality of Life*; Blood Glucose Self-Monitoring/*statistics & numerical data ; Diabetes Mellitus, Type 1/*epidemiology ; Diabetes Mellitus, Type 2/*epidemiology ; Hypoglycemia/*epidemiology; Adolescent ; Adult ; Aged ; Canada/epidemiology ; Circadian Rhythm ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/psychology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/psychology ; Female ; France/epidemiology ; Germany/epidemiology ; Humans ; Hypoglycemia/blood ; Hypoglycemia/psychology ; Italy/epidemiology ; Male ; Middle Aged ; Netherlands/epidemiology ; Online Systems ; Outcome Assessment, Health Care ; Population Surveillance ; Severity of Illness Index ; Sickness Impact Profile ; Spain/epidemiology ; Sweden/epidemiology ; United Kingdom/epidemiology ; United States/epidemiology
    • Abstract:
      Aims: The purpose of this study was to explore the burden and impact of non-severe nocturnal hypoglycaemic events (NSNHEs) on diabetes management, patient functioning and well-being in order to better understand the role that NSNHEs play in caring for persons with diabetes and facilitate optimal diabetes treatment management strategies.
      Methods: A 20-min survey assessing the impact of NSNHEs was administered to patients with self-reported diabetes age 18 or older via the Internet in nine countries (USA, UK, Germany, Canada, France, Italy, Spain, The Netherlands and Sweden) who experienced an NSNHE in the last month. Questions captured reasons for and length of the event, and impacts on diabetes management, daily function, sleep and well-being.
      Results: A total of 20 212 persons with Type 1 diabetes mellitus (T1DM) and Type 2 diabetes mellitus (T2DM) were screened of which 2108 respondents were eligible. Respondents initiated, on average, an additional 3.6 glucose monitoring tests, and did not resume usual functioning for an average of 3.4 hours after the NSNHE. Of the respondents using insulin, 15.8% decreased their insulin dose over an average of 3.6 days. NSNHEs also impacted sleep, with 10.4% not returning to sleep that night. Next day functioning was affected with 60.3% (n = 1273) feeling the need to take a nap and/or rest (with 65.5% of those actually taking a nap/rest) and 40.2% (n = 848) wanting to go to bed earlier than usual. A total of 21.4% were restricted in their driving the next day. These events also resulted in decreased well-being with 39.6% of respondents feeling 'emotional low' the following day.
      Conclusions: NSNHEs have serious consequences for patients. Greater attention to patient and physician education regarding the burden of NSNHEs and incorporation of corrective actions in treatment plans is needed to facilitate patients reaching optimal glycaemic control.
      (© 2013 Blackwell Publishing Ltd.)
    • References:
      J Med Econ. 2012;15(1):77-86. (PMID: 22029460)
      Ann N Y Acad Sci. 2008;1129:287-304. (PMID: 18591489)
      Diabetes Care. 2012 Jun;35(6):1279-84. (PMID: 22511257)
      Sleep. 2006 Aug;29(8):1009-14. (PMID: 16944668)
      Clin Exp Hypertens. 2008 Apr;30(3):183-90. (PMID: 18425698)
      QJM. 2007 Jun;100(6):345-50. (PMID: 17504861)
      JAMA. 2008 Dec 24;300(24):2859-66. (PMID: 19109114)
      Qual Life Res. 2013 Jun;22(5):997-1004. (PMID: 22825805)
      Diabetes Obes Metab. 2008 Jun;10 Suppl 1:16-24. (PMID: 18435670)
      Arch Intern Med. 2001 Jul 9;161(13):1653-9. (PMID: 11434798)
      N Engl J Med. 2011 Mar 3;364(9):818-28. (PMID: 21366473)
      Curr Med Res Opin. 2005 Sep;21(9):1477-83. (PMID: 16197667)
      Diabetes Metab Syndr Obes. 2012;5:57-74. (PMID: 22563248)
      Arch Intern Med. 2003 Jan 27;163(2):205-9. (PMID: 12546611)
      J Safety Res. 2008;39(3):269-72. (PMID: 18571567)
      Sleep. 2008 May;31(5):619-26. (PMID: 18517032)
      Value Health. 2011 Jul-Aug;14(5):665-71. (PMID: 21839404)
      J Med Econ. 2012;15(5):869-77. (PMID: 22510017)
      Diabet Med. 1991 Apr;8(3):217-22. (PMID: 1828735)
    • Publication Date:
      Date Created: 20130129 Date Completed: 20131230 Latest Revision: 20220408
    • Publication Date:
      20231215
    • Accession Number:
      PMC3662999
    • Accession Number:
      10.1111/dom.12070
    • Accession Number:
      23350726